Results 161 to 170 of about 10,434 (181)

MEDROXYPROGESTERONE ACETATE PROVES USEFUL

InPharma, 1977
openaire   +1 more source

Safety of depot medroxyprogesterone acetate

The Lancet, 1991
MichèleG Bonhomme, D Malcolm Potts, JudithA Fortney, MelissaY Allen   +3 more
openaire   +1 more source

State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now

Ca-A Cancer Journal for Clinicians, 2016
Susan M Swetter
exaly  

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2016
Robert A Smith, Stacey A Fedewa, Joannie Lortet-Tieulent   +2 more
exaly  

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler
exaly  

Cancer screening, prevention, and treatment in people with mental illness

Ca-A Cancer Journal for Clinicians, 2016
Ana Stefancic, Amy T Cunningham, Richard C Wender   +2 more
exaly  

การใช้ Medroxyprogesterone Acetate ขัดขวางการเป็นสัดในสุนัขเพศเมีย

The Thai Journal of Veterinary Medicine, 1986
openaire   +1 more source

534 Medroxyprogesterone acetate (MAP) pharmacokinetics

Journal of Steroid Biochemistry, 1983
F. Pannuti, C.M. Camaggi, E. Strocchi, A. Martoni   +3 more
openaire   +1 more source

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith
exaly  

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Ca-A Cancer Journal for Clinicians, 2016
Carol E Desantis, Ann Goding Sauer Msph, Robert A Smith   +2 more
exaly